[Federal Register Volume 67, Number 104 (Thursday, May 30, 2002)]
[Notices]
[Pages 37846-37847]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-13446]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Research Resources; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is herey given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Center for Research Resources 
Special Emphasis Panel, Clinical Research.
    Date: May 28, 2002.
    Time: 10 a.m. to Adjournment.
    Agenda: To review and evaluate grant applications.
    Place: Office of Review, National Center for Research Resources, 
6705 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference 
Call).

[[Page 37847]]

    Contact Person: Sheryl K. Brining, Phd, Scientific Review 
Administrator, Office of Review, National Center for Research 
Resources, National Institutes of Health, One Rockledge Centre, MSC 
7965, 6705 Rockledge Drive, Suite 6018, Bethesda, MD 20892. 301-435-
0809. [email protected].
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine, 93.306; 93.333, Clinical Research, 93.333; 
93.371, Biomedical Technology; 93.389, Research Infrastructure, 
National Institutes of Health, HHS)

    Dated: May 21, 2002.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 02-13446 Filed 5-29-02; 8:45 am]
BILLING CODE 4140-01-M